Correction of leptinresistance. New therapeutic strategy at a metabolic syndrome
Aim. To study efficiency of correction hyperleptinemie and infringements of a carbohydrate exchange at patients with a metabolic syndrome under influence of the therapy based on use of a agonist I1-imidazoline receptors moxonidine. Material and methods. 50 patients are included in research with an arterial hypertension and a metabolic syndrome by which therapy moxonidine was spent. On a background of treatment the control of a level the control of arterial pressure, according to casual values and daily monitoring, and also levels of glucose, insulin and leptin blood was carried out. Results. On a background of treatment moxonidine decrease in levels of insulin and leptin blood that was combined with antihypertension effect of a preparation is ascertained.